These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15486464)

  • 1. The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.
    Kuipers F; Claudel T; Sturm E; Staels B
    Rev Endocr Metab Disord; 2004 Dec; 5(4):319-26. PubMed ID: 15486464
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of farnesoid X receptor in cholestasis.
    Yuan ZQ; Li KW
    J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.
    Kok T; Hulzebos CV; Wolters H; Havinga R; Agellon LB; Stellaard F; Shan B; Schwarz M; Kuipers F
    J Biol Chem; 2003 Oct; 278(43):41930-7. PubMed ID: 12917447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of FXR in disorders of bile acid homeostasis.
    Eloranta JJ; Kullak-Ublick GA
    Physiology (Bethesda); 2008 Oct; 23():286-95. PubMed ID: 18927204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism.
    Willson TM; Jones SA; Moore JT; Kliewer SA
    Med Res Rev; 2001 Nov; 21(6):513-22. PubMed ID: 11607932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts.
    Houten SM; Auwerx J
    Ann Med; 2004; 36(7):482-91. PubMed ID: 15513299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FXR, a multipurpose nuclear receptor.
    Lee FY; Lee H; Hubbert ML; Edwards PA; Zhang Y
    Trends Biochem Sci; 2006 Oct; 31(10):572-80. PubMed ID: 16908160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Farnesoid X receptor(FXR)].
    Fujii H
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():309-12. PubMed ID: 11351595
    [No Abstract]   [Full Text] [Related]  

  • 10. Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor.
    Howard WR; Pospisil JA; Njolito E; Noonan DJ
    Toxicol Appl Pharmacol; 2000 Mar; 163(2):195-202. PubMed ID: 10698678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T; Staels B; Kuipers F
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations.
    Cariello M; Piccinin E; Garcia-Irigoyen O; Sabbà C; Moschetta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1308-1318. PubMed ID: 28965883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXR: More than a bile acid receptor?
    Caron S; Cariou B; Staels B
    Endocrinology; 2006 Sep; 147(9):4022-4. PubMed ID: 16912235
    [No Abstract]   [Full Text] [Related]  

  • 14. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear receptors, bile-acid detoxification, and cholestasis.
    Chen J; Raymond K
    Lancet; 2006 Feb; 367(9509):454-6. PubMed ID: 16473109
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy.
    Van Mil SW; Milona A; Dixon PH; Mullenbach R; Geenes VL; Chambers J; Shevchuk V; Moore GE; Lammert F; Glantz AG; Mattsson LA; Whittaker J; Parker MG; White R; Williamson C
    Gastroenterology; 2007 Aug; 133(2):507-16. PubMed ID: 17681172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
    Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
    J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders.
    Molinaro A; Marschall HU
    Biochem Soc Trans; 2022 Feb; 50(1):361-373. PubMed ID: 35191955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the bile acid receptor FXR].
    Li S; Zhang ZW; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):314-8. PubMed ID: 14992012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist of farnesoid X receptor protects against bile acid induced damage and oxidative stress in mouse placenta--a study on maternal cholestasis model.
    Wu WB; Xu YY; Cheng WW; Wang YX; Liu Y; Huang D; Zhang HJ
    Placenta; 2015 May; 36(5):545-51. PubMed ID: 25747729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.